Akèy › Maladi Crohn › Lwizyàn › Lafayette
Etid klinik pou Maladi Crohn nan Lafayette, LA
7 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Lafayette (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Ap rekriteFaz 4
- Combined Gastro LLC, Lafayette
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Gastroenterology Clinic of Acadiana, Lafayette
A Study of Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2/3
- Gastroenterology Clinic of Acadiana, Lafayette
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Ap rekriteFaz 3
- Care Access - New Iberia, New Iberia · 19 mi lwen
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Care Access - New Iberia-Site Number: 8400031, New Iberia · 19 mi lwen
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Gastroenterology Clinic of Acadiana, Lafayette
A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
Ap rekriteFaz 2
- Mirador Therapeutics Selected Site, Lafayette
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Tyler, TX17 etid
- Houston, TX17 etid
- Orlando, FL17 etid
- Atlanta, GA17 etid
- San Antonio, TX15 etid
- San Diego, CA15 etid
- Los Angeles, CA15 etid
Lòt etid nan Lafayette
- Kolit Ulseratif5 etid
- Obèsite4 etid
- Maladi fwa steatotik3 etid
- Sipwa3 etid
- Ensifizyans kadyak3 etid
- Kansè Vezik ki pa envazif miskilè3 etid
- Kansè vejik3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.